Microbot Medical (NASDAQ:MBOT – Get Free Report) is anticipated to announce its earnings results before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ($0.18) per share for the quarter.
Microbot Medical Stock Performance
Shares of NASDAQ MBOT opened at $1.60 on Tuesday. Microbot Medical has a fifty-two week low of $0.82 and a fifty-two week high of $3.38. The company has a market cap of $55.59 million, a price-to-earnings ratio of -2.00 and a beta of 1.60. The business’s 50 day moving average price is $1.75 and its 200-day moving average price is $1.30.
Wall Street Analyst Weigh In
Separately, HC Wainwright increased their target price on Microbot Medical from $7.00 to $9.00 and gave the stock a “buy” rating in a research note on Friday, January 24th.
About Microbot Medical
Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.
Read More
- Five stocks we like better than Microbot Medical
- Energy and Oil Stocks Explained
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- What to Know About Investing in Penny Stocks
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Why Invest in High-Yield Dividend Stocks?
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.
